TWO SIGMA INVESTMENTS, LP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 282.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2014$74,000
+5.7%
40,205
+39.5%
0.00%
Q3 2014$70,000
-49.3%
28,818
-24.1%
0.00%
-100.0%
Q2 2014$138,000
-33.7%
37,944
-29.2%
0.00%0.0%
Q4 2013$208,000
+144.7%
53,572
+186.4%
0.00%0.0%
Q3 2013$85,000
-52.0%
18,703
-48.0%
0.00%0.0%
Q2 2013$177,00035,9590.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,230,789$2,400,0002.03%
Camber Capital Management LP 7,274,577$14,185,0000.97%
MENORA MIVTACHIM HOLDINGS LTD. 1,200,680$2,341,0000.18%
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) 618,684$1,206,0000.11%
Visium Asset Management, LP 2,500,000$4,875,0000.07%
FEDERATED HERMES, INC. 7,456,566$14,540,0000.04%
Baillie Gifford 6,481,624$12,639,0000.02%
NJ State Employees Deferred Compensation Plan 40,000$78,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 327,344$638,0000.01%
Psagot Value Holdings Ltd. 122,501$239,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders